FXH
First Trust Health Care AlphaDEX Fund·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
918.26MUSD
Fund Flows (1Y)
-175.84MUSD
Dividend Yield
0.73%
Discount/Premium to NAV
-0.07%
Shares Outstanding
8.10M
Expense Ratio
0.60%
About First Trust Health Care AlphaDEX Fund
Issuer
First Trust Advisors L.P.
Brand
First Trust
Inception Date
May 8, 2007
Structure
Open-Ended Fund
Index Tracked
StrataQuant Health Care Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FXH tracks a quant-driven index that attempts to achieve excess returns by selecting health care stocks based on growth and value factors, and equal-weighting them in tiers. The portfolio offers noteworthy mid-cap exposure, downplaying familiar large-cap names relative to cap-weighted peer funds. Additionally, FXH underweights pharmaceuticals relative to the market, but allows a significant exposure to biotechnology and healthcare providers. Overall, this fund offers a "smart beta” approach to the US health care space, tilting away from big pharma and towards other facets of health care. The index is reconstituted and rebalanced on a quarterly basis.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Multi-factor
Geography
U.S.
Weighting Scheme
Tiered
Selection Criteria
Multi-factor
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -3.01% | +4.52% | +1.53% | +4.54% | +2.23% | +3.29% |
NAV Total Return | -4.05% | +3.45% | -0.56% | +5.39% | +3.24% | +3.23% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
98.86%
1.14%
Category
Ratio
North America
98.86%
Europe
1.14%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Medium-Cap Growth
Targets mid-cap companies with significant growth opportunities. These ETFs focus on firms expected to experience faster growth in terms of revenue and earnings.
Top 10 Holdings
Symbol
Ratio
OGN
Organon
2.56%
PFE
Pfizer
2.38%
IONS
Ionis Pharmaceuticals
2.38%
HCA
HCA Healthcare
2.34%
BIIB
Biogen
2.34%
INCY
Incyte
2.30%
MOH
Molina Healthcare
2.28%
LLY
Eli Lilly
2.28%
CAH
Cardinal Health
2.23%
MEDP
Medpace Holdings
2.22%
Top 10 Weight 23.31%
77 Total Holdings
Is SPY better than FXH?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-09-25 | 2025-09-25 | 2025-09-30 | 0.582 |
| 2025-06-26 | 2025-06-26 | 2025-06-30 | 0.062 |
| 2025-03-27 | 2025-03-27 | 2025-03-31 | 0.067 |
| 2024-12-13 | 2024-12-13 | 2024-12-31 | 0.090 |
| 2024-09-26 | 2024-09-26 | 2024-09-30 | 0.126 |
| 2024-06-27 | 2024-06-27 | 2024-06-28 | 0.109 |
| 2024-03-21 | 2024-03-22 | 2024-03-28 | 0.106 |
Show more
How Much Does FXH Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy FXH?
Fund Flows
